Evaxion A (EVAX) Receivables - Other (2019 - 2024)
Evaxion A's (EVAX) quarterly Receivables - Other came in at $65000.0 in Q4 2024, down 39.81% YoY from $108000.0 in Q1 2024, and down 39.81% on a QoQ basis from $108000.0 in Q4 2023.
Evaxion A (EVAX) Receivables - Other (2019 - 2024) Analysis & Trends
Evaxion A (EVAX) has 6 years of Receivables - Other data on file, last reported at $65000.0 in Q4 2024.
- Quarterly Receivables - Other fell 39.81% year-over-year to $65000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $65000.0 (down 39.81% YoY) and the FY2024 annual result came in at $65000.0, down 39.81% from the prior year.
- Receivables - Other eased to $65000.0 in Q4 2024, from $108000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $113000.0 in Q4 2021 to a low of $7000.0 in Q4 2020.
- A 5-year average of $60600.0 and a median of $65000.0 in 2024 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2021 — Receivables - Other soared 1514.29% — and 2022, when it plunged 91.15%.
- Tracing EVAX's Receivables - Other over 5 years: stood at $7000.0 in 2020, then soared by 1514.29% to $113000.0 in 2021, then sank by 91.15% to $10000.0 in 2022, then jumped by 980.0% to $108000.0 in 2023, then sank by 39.81% to $65000.0 in 2024.
- The last three Receivables - Other figures came in at $65000.0 (Q4 2024), $108000.0 (Q4 2023), and $10000.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.18 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.98 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.37 Bn | 59.19 Bn | 1.37 Bn |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.75 Bn | 9.35 Bn | 668.28 Mn |
| 8 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.03 Bn | 26.20 Bn | - |
| 10 | Evaxion A | 27.61 Mn | 27.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 65,000.00 |
| Dec 31, 2024 | 65,000.00 |
| Dec 31, 2023 | 108,000.00 |
| Dec 31, 2023 | 108,000.00 |
| Dec 31, 2022 | 10,000.00 |
| Dec 31, 2022 | 10,000.00 |
| Dec 31, 2021 | 113,000.00 |
| Dec 31, 2021 | 113,000.00 |
| Dec 31, 2020 | 7,000.00 |
| Dec 31, 2020 | 7,000.00 |
| Dec 31, 2019 | 32,000.00 |
| Dec 31, 2019 | 32,000.00 |